United Therapeutics Corporation (UTHR) financials · rev $3.18B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
United Therapeutics Corporation (UTHR) rev $3.18B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $3.18B | $2.88B |
| Cost of Revenue | $384.4M | $309.7M |
| Gross Profit | $2.80B | $2.57B |
| Operating Income | $1.49B | $1.38B |
| Net Income | $1.33B | $1.20B |
| EPS (Diluted) | $27.86 | $24.64 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $7.88B | $7.36B |
| Current Assets | $3.70B | $3.87B |
| Cash & Equivalents | $1.56B | $1.70B |
| Inventory | $183.1M | $157.9M |
| PP&E | $1.73B | $1.22B |
| Total Liabilities | $783.8M | $920.0M |
| Current Liabilities | $560.6M | $738.1M |
| Shareholders' Equity | $7.10B | $6.44B |
| Retained Earnings | $8.56B | $7.22B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $1.56B | $1.33B |
| CapEx | $520.5M | $246.5M |
| Investing Cash Flow | -$551.3M | $417.2M |
| Financing Cash Flow | -$1.15B | -$1.25B |
| Net Change in Cash | -$140.1M | $489.5M |
| Free Cash Flow | $1.04B | $1.08B |
FAQ
What is UTHR P/E and revenue?
United Therapeutics Corporation (UTHR) rev $3.18B.
What is UTHR revenue?
United Therapeutics Corporation last cached revenue is $3.18B (FY2025).
Is UTHR profitable?
United Therapeutics Corporation last cached net income is $1.33B (FY2025).
What are UTHR total assets?
United Therapeutics Corporation last cached total assets are $7.88B (FY2025).
What is UTHR free cash flow?
United Therapeutics Corporation last cached free cash flow is $1.04B (FY2025).
Not investment advice. Cached statements, not a live tape.